89bio, Inc. Operating Lease, Expense
89bio, Inc. reported Operating Lease, Expense of $1.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2025-02-27
- 89bio, Inc. operating lease, expense for fiscal 2024 was $1.00M, a 233.33% increase from fiscal 2023.
- 89bio, Inc. operating lease, expense for fiscal 2023 was $300.00K, a 50.00% increase from fiscal 2022.
- 89bio, Inc. operating lease, expense for fiscal 2022 was $200.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2024-12-31 | $1.00M 10-K · filed 2025-02-27 |
| 2023-12-31 | $300.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | $200.00K 10-K · filed 2025-02-27 |